Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma
{{output}}
Introduction: Since the July 2017 National Comprehensive Cancer Network (NCCN) malignant pleural mesothelioma (MPM) guideline revision recommended second-line immune checkpoint inhibitors (ICIs), studies have suggested a greater ... ...
